NET LOSS PER SHARE (Tables)

3 Months Ended

Mar. 31, 2023

The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the three months ended March 31 (in thousands, except for per share amounts):


	Three Months Ended March 31,
	2023		2022
Loss from continuing operations, net noncontrolling interests and accrued preferred stock dividends	$	(112,236)	$	(187,057)
Loss from discontinued operations	(74,669)		(17,115)
Net loss attributable to Bright Health Group, Inc. common shareholders	$	(186,905)	$	(204,172)
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted	631,534		628,765
Basic and diluted loss per share attributable to Bright Health Group, Inc. common shareholders
Continuing operations	$	(0.18)	$	(0.30)
Discontinued operations	$	(0.12)	$	(0.02)
Net loss per share attributable to common stockholders, basic and diluted	$	(0.30)	$	(0.32)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share because including them would have had an anti-dilutive effect for the three months ended March 31 (in thousands):


	Three Months Ended March 31,
	2023	2022
Redeemable convertible preferred stock (as converted to common stock)	322,458	166,852
Stock options to purchase common stock	61,672	72,974
Restricted stock units	79,954	36,792
Total	464,084	276,618